Evidence map›Paper›PMID 26984317›Full record

ArticleIntensive care medicine2016

Therapeutic management of peritonitis: a comprehensive guide for intensivists.

P Montravers, S Blot, G Dimopoulos, C Eckmann, P Eggimann, X Guirao, J A Paiva, G Sganga, J De Waele

Abstract read
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Review
  5. Prognostic impact ofAnnals of intensive care · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Guidelines for Antibiotics Prescription in Critically Ill Patients.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Optimized Treatment of Nosocomial Peritonitis.Antibiotics (Basel, Switzerland) · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 8 countries.

P MontraversAPHP, CHU Bichat-Claude Bernard, Département d'Anesthésie Réanimation, Université Denis Diderot, PRESS Sorbonne Cité, Paris, France. philippe.montravers@aphp.fr.
S BlotDepartment of Internal Medicine, Ghent University, Ghent, Belgium.
G DimopoulosDepartment of Critical Care, University Hospital Attikon, Medical School, University of Athens, Athens, Greece.
C EckmannDepartment of General, Visceral and Thoracic Surgery, Klinikum Peine, Peine, Germany.
P EggimannDepartment of Intensive Care Medicine and Burn Center, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
X GuiraoDepartment of Endocrine and Head and Neck Surgery, Corporació Sanitaria del Parc Tauli, University Hospital, Sabadell, Barcelona, Spain.
J A PaivaEmergency and Intensive Care Department, Centro Hospitalar S. João EPE, Porto, Portugal.
G SgangaDepartment of Surgery, Catholic University of Sacred Heart, Policlinico A Gemelli, Rome, Italy.
J De WaeleDepartment of Critical Care Medicine, Ghent University Hospital, Ghent, Belgium.
Assistance Publique – Hôpitaux de Paris · FRCorporació Sanitària Parc Taulí · ESGhent University · BEGhent University Hospital · BENational and Kapodistrian University of Athens · GRUniversidade do Porto · PTUniversità Cattolica del Sacro Cuore · ITUniversity Hospital of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe management of peritonitis in critically ill patients is becoming increasingly complex due to their changing characteristics and the growing prevalence of multidrug-resistant (MDR) bacteria.

methodsA multidisciplinary panel summarizes the latest advances in the therapeutic management of these critically ill patients.

resultsAppendicitis, cholecystitis and bowel perforation represent the majority of all community-acquired infections, while most cases of healthcare-associated infections occur following suture leaks and/or bowel perforation. The micro-organisms involved include a spectrum of Gram-positive and Gram-negative bacteria, as well as anaerobes and fungi. Healthcare-associated infections are associated with an increased likelihood of MDR pathogens. The key elements for success are early and optimal source control and adequate surgery and appropriate antibiotic therapy. Drainage, debridement, abdominal cleansing, irrigation, and control of the source of contamination are the major steps to ensure source control. In life-threatening situations, a "damage control" approach is the safest way to gain time and achieve stability. The initial empirical antiinfective therapy should be prescribed rapidly and must target all of the micro-organisms likely to be involved, including MDR bacteria and fungi, on the basis of the suspected risk factors. Dosage adjustment needs to be based on pharmacokinetic parameters. Supportive care includes pain management, optimization of ventilation, haemodynamic and fluid monitoring, improvement of renal function, nutrition and anticoagulation.

conclusionsThe majority of patients with peritonitis develop complications, including worsening of pre-existing organ dysfunction, surgical complications and healthcare-associated infections. The probability of postoperative complications must be taken into account in the decision-making process prior to surgery.

Indexed as

Practice Guidelines as TopicAdultAgedAged, 80 and overAnti-Bacterial AgentsCritical CareCritical IllnessFemaleHumansMaleMiddle AgedPeritonitisAnti-Bacterial AgentsFungal infectionIntra-abdominal hypertensionMultidrug-resistant bacteriaPeritonitisPostoperative complicationsSource control

Identifiers

PMID26984317
OpenAlexW2334331369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.